Respilène

Respilène may be available in the countries listed below.

Ingredient matches for Respilène

Pholcodine

Pholcodine is reported as an ingredient of Respilène in the following countries:

• France

International Drug Name Search

Doctors Foster and Smith Iodoform Powder

Dosage Form: FOR ANIMAL USE ONLY

Drs. Foster and Smith Ear Powder gives prompt relief from irritated, itching ears of non-parasitic origin. It stops scratching and aids in the inhibition of bacterial growth. Eliminates unpleasant ear odors. Drs. Foster and Smith Ear Powder dries ear discharge and makes it easy to remove. For topical use within the ears. For Dogs and Cats.

DIRECTIONS

Hold application tip one inch from ear canal. Squeeze drs. Foster and Smith Ear Powder directly into the ear. In severe cases treat daily. Weekly application will help keep your pet's ears in good condition.

Drs. Foster and Smith Ear Powder is also an excellent aid in removing excess unwanted hair from the ears. Powder applied into the ear prior to attempting to remove the hair makes it easier to grip, less painful to the pet and relieves any irritation that may be caused.

ACTIVE INGREDIENT

5% Iodoform in an inert base.

INACTIVE INGREDIENT

Talc

For Questions or to reorder:

1-800-562-7169 Drsfostersmith.com

Doctors

Foster and Smith

Ear

Powder

• Prompt relief for itching and irritated ears


• Stops ear odors

MET WT 1 oz. (28 g)


Formulated by our veterinarian

Keep out of reach of children and pets to prevent unwanted consumption

DOCTORS FOSTER AND SMITH  iodoform  powder

Product Information Product Type OTC ANIMAL DRUG NDC Product Code (Source) 65713-910 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength IODOFORM (IODOFORM) IODOFORM 1.4 g  in 28 g

Inactive Ingredients Ingredient Name Strength TALC

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 65713-910-01 28 g In 1 BOTTLE None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/01/2001

Labeler - Doctors Foster and Smith (122135148)

Registrant - United Pet Group (931135730)

Establishment
Name	Address	ID/FEI	Operations
JUNGLE LABORATORIES CORPORATION		032615270	manufacture

Revised: 02/2010Doctors Foster and Smith

Ketodil

Ketodil may be available in the countries listed below.

Ingredient matches for Ketodil

Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Ketodil in the following countries:

• Bangladesh

International Drug Name Search

Divalproex Delayed-Release Tablets

Pronunciation: dye-VAL-proe-ex
Generic Name: Divalproex
Brand Name: Depakote

Life-threatening liver failure has occurred in patients taking Divalproex Delayed-Release Tablets. Children younger than 2 years old are at increased risk of developing life-threatening liver damage, especially those on more than 1 medicine to treat seizures, and those with metabolic disorders, severe seizure disorders accompanied by retardation, or organic brain disease. Contact your doctor immediately if you or your child experiences a general feeling of discomfort, sluggishness, weakness, severe drowsiness, swelling of the face, loss of appetite, vomiting, or loss of seizure control. Liver function tests may be performed before and during therapy with Divalproex Delayed-Release Tablets. Be sure to keep all doctor and lab appointments.

Divalproex Delayed-Release Tablets can cause severe birth defects if it is used during pregnancy. Contact your doctor if you become pregnant or think you may be pregnant while taking Divalproex Delayed-Release Tablets. Divalproex Delayed-Release Tablets comes with an additional patient leaflet, "Important Information for Women Who Could Become Pregnant." Read it carefully.

Cases of life-threatening inflammation of the pancreas have occurred with the use of Divalproex Delayed-Release Tablets. Report any stomach pain, nausea, vomiting, or loss of appetite to your doctor at once.

Divalproex Delayed-Release Tablets are used for:

Controlling certain types of seizures in the treatment of epilepsy. It is also used to treat the manic phase of bipolar disorders (manic-depressive illness), and to prevent migraine headaches.

Divalproex Delayed-Release Tablets are an anticonvulsant. It works by reducing or preventing the number of seizures by controlling the abnormal activity of nerve impulses in the brain and central nervous system. Exactly how it works to treat bipolar disorder and migraine headache is not known.

Do NOT use Divalproex Delayed-Release Tablets if:

• you are allergic to any ingredient in Divalproex Delayed-Release Tablets


• you have liver problems or a urea cycle disorder

Contact your doctor or health care provider right away if any of these apply to you.

Video: Treatment for Depression

Treatments for depression are getting better everyday and there are things you can start doing right away.

Before using Divalproex Delayed-Release Tablets:

Some medical conditions may interact with Divalproex Delayed-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, are breast-feeding, or are of childbearing age


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of alcohol abuse, liver problems, metabolic disease, blood disease, HIV infection, cytomegalovirus (CMV) infection, high blood levels of ammonia or glutamine, low body temperature, low levels of albumin, brain problems (eg, organic brain disease), mental retardation, inflammation of the pancreas, kidney problems, or low levels of white blood cells, or if you are scheduled for surgery


• if you have a history of ornithine transcarbamylase deficiency or unexplained coma


• if you have a family history of urea cycle disorders or unexplained infant deaths


• if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions


• if you take any other medicine for seizures

Some MEDICINES MAY INTERACT with Divalproex Delayed-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Benzodiazepines (eg, diazepam), carbamazepine, erythromycin, felbamate, fluoxetine, guanfacine, isoniazid, ketoconazole, risperidone, or salicylates (eg, aspirin) because the risk of serious side effects of Divalproex Delayed-Release Tablets, including changes in vision or other vision problems, clumsiness or unsteadiness, drowsiness, nausea, or vomiting, may be increased


• Clonazepam because the risk of seizures may be increased


• Topiramate because the risk of high ammonium levels, brain problems, or an unusual drop in body temperature may be increased


• Acyclovir, cancer medicines, carbapenem antibiotics (eg, ertapenem, imipenem, meropenem), cholestyramine, hydantoins (eg, phenytoin), mefloquine, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), oral contraceptives (eg, birth control pills), or rifampin because they may decrease Divalproex Delayed-Release Tablets's effectiveness


• Anticoagulants (eg, warfarin), barbiturates (eg, phenobarbital), ethosuximide, lamotrigine, methylphenidate, primidone, tolbutamide, tricyclic antidepressants (eg, amitriptyline), or zidovudine because the risk of their side effects may be increased by Divalproex Delayed-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Divalproex Delayed-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Divalproex Delayed-Release Tablets:

Use Divalproex Delayed-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Divalproex Delayed-Release Tablets. Talk to your pharmacist if you have questions about this information.


• Take Divalproex Delayed-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Divalproex Delayed-Release Tablets whole. Do not break, crush, or chew before swallowing.


• Do not stop taking Divalproex Delayed-Release Tablets suddenly, especially if you are taking Divalproex Delayed-Release Tablets to prevent seizures. Suddenly stopping Divalproex Delayed-Release Tablets may cause severe seizures to occur. If you need to stop Divalproex Delayed-Release Tablets, your doctor will gradually lower your dose.


• Taking Divalproex Delayed-Release Tablets at the same time each day will help you remember to take it.


• Continue to take Divalproex Delayed-Release Tablets even if you feel well. Do not miss any doses. Divalproex Delayed-Release Tablets works best when there is a constant level of it in your body.


• If you miss a dose of Divalproex Delayed-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Divalproex Delayed-Release Tablets.

Important safety information:

• Divalproex Delayed-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Divalproex Delayed-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Divalproex Delayed-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Inflammation of the pancreas is a potentially life-threatening illness associated with Divalproex Delayed-Release Tablets. Symptoms include stomach pain, vomiting, or loss of appetite. Contact your doctor at once if any of these symptoms occur.


• Patients who take Divalproex Delayed-Release Tablets may be at increased risk for suicidal thoughts or actions. The risk may be greater in patients who have had suicidal thoughts or actions in the past. Patients who have bipolar (manic-depressive) illness may also have an increased risk for suicidal thoughts or actions. Watch patients who take Divalproex Delayed-Release Tablets closely. Contact the doctor at once if new, worsened, or sudden symptoms, such as depressed mood; anxious, restless, irritable behavior; panic attacks; or any unusual change in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.


• Divalproex Delayed-Release Tablets may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.


• Tell your doctor or dentist that you take Divalproex Delayed-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Diabetes patients - Divalproex Delayed-Release Tablets may cause the results of some tests for urine ketones to be wrong. Ask your doctor before you change your diet or the dose of your diabetes medicine.


• Divalproex Delayed-Release Tablets may increase the ammonia levels in your blood. Contact your doctor right away if you experience unexplained sluggishness and vomiting or mental changes.


• Divalproex Delayed-Release Tablets may cause an unusual drop in body temperature (hypothermia). Symptoms may include confusion, lack of energy, loss of coordination, shivering, slow heartbeat, slow or shallow breathing, slurred speech, or unusual drowsiness. Contact your doctor right away if you have any of these symptoms.


• Divalproex Delayed-Release Tablets may interfere with certain lab tests, including thyroid function. Be sure your doctor and lab personnel know you are taking Divalproex Delayed-Release Tablets


• Lab tests, including complete blood cell counts, blood ammonia levels, and liver function, may be performed while you use Divalproex Delayed-Release Tablets. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Divalproex Delayed-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness.


• Divalproex Delayed-Release Tablets should be used with extreme caution in CHILDREN younger than 10 years old; safety and effectiveness in these children have not been confirmed. CHILDREN younger than 2 years old may be at increased risk of serious liver problems.


• PREGNANCY and BREAST-FEEDING: Divalproex Delayed-Release Tablets has been shown to cause harm to the fetus. Use an effective form of birth control while you take Divalproex Delayed-Release Tablets. If you think you may be pregnant or if you wish to become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Divalproex Delayed-Release Tablets while you are pregnant. Divalproex Delayed-Release Tablets are found in breast milk. Do not breast-feed while you are taking Divalproex Delayed-Release Tablets.

Possible side effects of Divalproex Delayed-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Change in appetite; constipation; diarrhea; dizziness; drowsiness; hair loss; headache; indigestion; nausea; stomach cramps or pain; trouble sleeping; vomiting; weakness; weight changes.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal thinking; change in menstrual period; changes in behavior; chest pain; confusion; dark, tarry, or bloody stools; dark urine; difficulty speaking; difficulty urinating or other urination problems; extreme tiredness; fast or irregular heartbeat; hallucinations; hearing loss; involuntary movements of the arms and legs; involuntary movements or chewing movements of the face, jaw, mouth, or tongue; joint pain; lack of energy; loss of appetite; loss of coordination; loss of seizure control; memory loss; new or worsening mental or mood changes (eg, aggressiveness, agitation, anxiety, depression, exaggerated feeling of well-being, hostility, impulsiveness, inability to sit still, irritability, panic attacks, restlessness); nosebleed; pounding in the chest; red, swollen, blistered, or peeling skin; severe or persistent nausea, vomiting, or stomach pain; shortness of breath; suicidal thoughts or actions; swelling of the arms or legs; symptoms of infection (eg, fever, chills, sore throat); tremor; unusual bleeding or bruising; unusual weakness; vision changes or blurred vision; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Divalproex side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep; drowsiness; irregular heartbeat; loss of consciousness.

Proper storage of Divalproex Delayed-Release Tablets:

Store Divalproex Delayed-Release Tablets between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Divalproex Delayed-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Divalproex Delayed-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Divalproex Delayed-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If using Divalproex Delayed-Release Tablets for an extended period of time, obtain refills before your supply runs out.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Divalproex Delayed-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Divalproex resources

• Divalproex Side Effects (in more detail)
• Divalproex Dosage
• Divalproex Use in Pregnancy & Breastfeeding
• Drug Images
• Divalproex Drug Interactions
• Divalproex Support Group
• 129 Reviews for Divalproex - Add your own review/rating

Compare Divalproex with other medications

• Bipolar Disorder
• Epilepsy
• Hyperekplexia
• Mania
• Migraine Prevention

Ritemed Cimetidine

Ritemed Cimetidine may be available in the countries listed below.

Ingredient matches for Ritemed Cimetidine

Cimetidine

Cimetidine is reported as an ingredient of Ritemed Cimetidine in the following countries:

• Philippines

International Drug Name Search

Lagarmicin

Lagarmicin may be available in the countries listed below.

Ingredient matches for Lagarmicin

Erythromycin

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Lagarmicin in the following countries:

• Spain

International Drug Name Search

Duoplant Gel

Pronunciation: sal-ih-SILL-ik AS-id
Generic Name: Salicylic Acid
Brand Name: Examples include Duoplant and Sal-Plant

Duoplant Gel is used for:

Removing common warts and warts on the bottom of the foot (plantar warts). It may also be used for other skin conditions as determined by your doctor.

Duoplant Gel is a topical salicylate. It works by causing the skin to swell, soften, and then slough or peel in areas where it is applied.

Do NOT use Duoplant Gel if:

• you are allergic to any ingredient in Duoplant Gel


• you have diabetes or poor blood circulation

Contact your doctor or health care provider right away if any of these apply to you.

Before using Duoplant Gel:

Some medical conditions may interact with Duoplant Gel. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to aspirin or a nonsteroidal anti-inflammatory drug (NSAID) (eg, ibuprofen, naproxen, celecoxib)


• if you have liver or kidney problems, a skin infection, or skin irritation

Some MEDICINES MAY INTERACT with Duoplant Gel. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants, (eg, heparin, warfarin), aspirin, methotrexate, or sulfonylureas (eg, glipizide) because the risk of side effects may be increased by Duoplant Gel

This may not be a complete list of all interactions that may occur. Ask your health care provider if Duoplant Gel may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Duoplant Gel:

Use Duoplant Gel as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• First soak the wart in warm water for about 5 minutes. Dry thoroughly. Apply 1 drop at a time to sufficiently cover each wart. Let dry.


• Cover the area with a small adhesive bandage or dressing (if practical) unless your doctor has instructed you not to. Unless your hands are being treated, be sure to wash your hands after each application.


• If you miss a dose of Duoplant Gel, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Duoplant Gel.

Important safety information:

• Duoplant Gel is for external use only. Avoid getting Duoplant Gel in your eyes, nose, or mouth, or on the genitals. If contact with your eyes occurs, flush with water for 15 minutes. Do not inhale the vapors of Duoplant Gel.


• Do not use Duoplant Gel longer or more often than recommended by your doctor or on the package label.


• Check with your doctor before use if you have a condition that covers a large area of the body.


• Be sure to apply Duoplant Gel only to the affected area and not to normal healthy skin.


• Do not use Duoplant Gel on skin that is irritated, infected, or reddened.


• Do not use Duoplant Gel on open skin wounds, moles, birthmarks, genital warts, warts on the face, or warts growing hair.


• Do not use any other medicines or drying products on your skin unless your doctor instructs you otherwise.


• Duoplant Gel may interfere with certain lab test results. Make sure your doctor and lab personnel know you are using Duoplant Gel.


• Duoplant Gel is extremely flammable. Do not store or use Duoplant Gel near a fire or other open flame.


• Duoplant Gel may be harmful if swallowed. If you may have taken Duoplant Gel by mouth, contact your local poison control center or emergency room immediately.


• Duoplant Gel contains a salicylate, which has been linked to Reye syndrome. Do not use Duoplant Gel on children or teenagers during or after chickenpox, flu, or other viral infections without checking with your doctor or pharmacist.


• Caution is advised when using Duoplant Gel in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Duoplant Gel during pregnancy. It is unknown if Duoplant Gel is excreted in breast milk. If you are or will be breast-feeding while you are using Duoplant Gel, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of Duoplant Gel:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dry, peeling, red, or scaling skin.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe irritation.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Duoplant side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; diarrhea; dizziness; loss of appetite; loss of hearing; mental disturbances; nausea; rapid or difficult breathing; ringing in the ears; seizures; sluggishness; vomiting; yellowing of the skin or eyes.

Proper storage of Duoplant Gel:

Store Duoplant Gel at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not freeze. Do not store in the bathroom. Keep Duoplant Gel out of the reach of children and away from pets.

General information:

• If you have any questions about Duoplant Gel, please talk with your doctor, pharmacist, or other health care provider.


• Duoplant Gel is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duoplant Gel. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duoplant resources

• Duoplant Side Effects (in more detail)
• Duoplant Use in Pregnancy & Breastfeeding
• Duoplant Drug Interactions
• Duoplant Support Group
• 1 Review for Duoplant - Add your own review/rating

Compare Duoplant with other medications

• Acne
• Warts

ratio-Hemcort-HC

ratio-Hemcort-HC may be available in the countries listed below.

Ingredient matches for ratio-Hemcort-HC

Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of ratio-Hemcort-HC in the following countries:

• Canada

Zinc Acetate

Zinc Acetate is reported as an ingredient of ratio-Hemcort-HC in the following countries:

• Canada

International Drug Name Search

Paralytic Disorder Medications

There are currently no drugs listed for "Paralytic Disorder".

Drug List:

Teraflem

Teraflem may be available in the countries listed below.

Ingredient matches for Teraflem

Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Teraflem in the following countries:

• Venezuela

International Drug Name Search

Binograc

Binograc may be available in the countries listed below.

Ingredient matches for Binograc

Clofibrate

Clofibrate is reported as an ingredient of Binograc in the following countries:

• Japan

International Drug Name Search

Dexir Enfant

Dexir Enfant may be available in the countries listed below.

Ingredient matches for Dexir Enfant

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Dexir Enfant in the following countries:

• Belgium


• France

International Drug Name Search